바이오뱅크 시장 규모, 점유율, 동향 및 성장 분석 보고서(2026-2034년)

The Biobanking Market size is expected to reach USD 12.00 Billion in 2034 from USD 4.30 Billion (2025) growing at a CAGR of 12.07% during 2026-2034.

The biobanking market is poised for significant growth, driven by the increasing demand for biological samples and data for research and clinical applications. Biobanks play a crucial role in supporting biomedical research by providing access to a wide range of biological materials, including blood, tissue, and DNA samples. As the global focus on personalized medicine and genomics intensifies, the demand for biobanking services is expected to rise, positioning this market for robust expansion.

Moreover, advancements in biobanking technologies are driving innovation within the market. The development of automated sample processing, storage solutions, and data management systems is enhancing the efficiency and reliability of biobanks. These innovations not only improve sample integrity and accessibility but also facilitate the integration of biobanking with advanced research methodologies, such as high-throughput sequencing and bioinformatics. As research continues to explore new applications for biobanking, the market is likely to expand further, driven by the promise of improved research outcomes and collaboration.

Additionally, the growing emphasis on ethical considerations and regulatory compliance is shaping the biobanking landscape. As biobanks navigate complex ethical frameworks and regulations regarding sample collection and usage, the demand for transparent and compliant biobanking practices is likely to increase. This trend is particularly relevant in the context of patient consent and data privacy, where maintaining trust and transparency is essential. As the biobanking market continues to evolve, the combination of technological advancements, ethical considerations, and a focus on collaboration will play a crucial role in shaping its future trajectory.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Product & Service

• Equipment (Storage Equipment, Sample Analysis Equipment, Sample Processing Equipment, Sample Transport Equipment)
• Consumables ( Storage Consumables, Analysis Consumables, Processing Consumables, Collection Consumables)
• Services
• Software

By Sample Type

• Blood Products
• Human Tissues
• Cell Lines
• Nucleic Acids
• Biological Fluids
• Human Waste Products

By Storage Type

• Manual Storage
• Automated Storage

By Ownership

• Universities
• National/Regional Agencies
• Non-Profit Organizations
• Private Organizations

By Application

• Regenerative Medicine
• Life Science Research
• Clinical Research

By End user

• Pharmaceutical & Biotechnology Companies and CROs
• Academic & Research Institutes
• Hospitals

COMPANIES PROFILED

• Merck KGaA, Thermo Fisher Scientific, Inc, Becton, Dickinson and Company, PHC Holdings Corporation, Avantor, Inc, Greiner Holding AG, Azenta, Inc, Tecan Trading AG, Hamilton Company, Cryoport, Inc, Micronic, AMSBIO, Bay Biosciences LLC, BioKryo, SPT Labtech

We can customise the report as per your requriements

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL BIOBANKING MARKET: BY PRODUCT & SERVICE 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Product & Service
• 4.2. Equipment (Storage Equipment, Sample Analysis Equipment, Sample Processing Equipment, Sample Transport Equipment) Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Consumables ( Storage Consumables, Analysis Consumables, Processing Consumables, Collection Consumables) Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Services Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.5. Software Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL BIOBANKING MARKET: BY SAMPLE TYPE 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Sample Type
• 5.2. Blood Products Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Human Tissues Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Cell Lines Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.5. Nucleic Acids Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.6. Biological Fluids Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.7. Human Waste Products Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL BIOBANKING MARKET: BY STORAGE TYPE 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast Storage Type
• 6.2. Manual Storage Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Automated Storage Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL BIOBANKING MARKET: BY OWNERSHIP 2022-2034 (USD MN)

• 7.1. Market Analysis, Insights and Forecast Ownership
• 7.2. Universities Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.3. National/Regional Agencies Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.4. Non-Profit Organizations Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.5. Private Organizations Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 8. GLOBAL BIOBANKING MARKET: BY APPLICATION 2022-2034 (USD MN)

• 8.1. Market Analysis, Insights and Forecast Application
• 8.2. Regenerative Medicine Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 8.3. Life Science Research Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 8.4. Clinical Research Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 9. GLOBAL BIOBANKING MARKET: BY END USER 2022-2034 (USD MN)

• 9.1. Market Analysis, Insights and Forecast End User
• 9.2. Pharmaceutical & Biotechnology Companies and CROs Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 9.3. Academic & Research Institutes Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 9.4. Hospitals Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 10. GLOBAL BIOBANKING MARKET: BY REGION 2022-2034(USD MN)

• 10.1. Regional Outlook
• 10.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 10.2.1 By Product & Service
  • 10.2.2 By Sample Type
  • 10.2.3 By Storage Type
  • 10.2.4 By Ownership
  • 10.2.5 By Application
  • 10.2.6 By End User
  • 10.2.7 United States
  • 10.2.8 Canada
  • 10.2.9 Mexico
• 10.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 10.3.1 By Product & Service
  • 10.3.2 By Sample Type
  • 10.3.3 By Storage Type
  • 10.3.4 By Ownership
  • 10.3.5 By Application
  • 10.3.6 By End User
  • 10.3.7 United Kingdom
  • 10.3.8 France
  • 10.3.9 Germany
  • 10.3.10 Italy
  • 10.3.11 Russia
  • 10.3.12 Rest Of Europe
• 10.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 10.4.1 By Product & Service
  • 10.4.2 By Sample Type
  • 10.4.3 By Storage Type
  • 10.4.4 By Ownership
  • 10.4.5 By Application
  • 10.4.6 By End User
  • 10.4.7 India
  • 10.4.8 Japan
  • 10.4.9 South Korea
  • 10.4.10 Australia
  • 10.4.11 South East Asia
  • 10.4.12 Rest Of Asia Pacific
• 10.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 10.5.1 By Product & Service
  • 10.5.2 By Sample Type
  • 10.5.3 By Storage Type
  • 10.5.4 By Ownership
  • 10.5.5 By Application
  • 10.5.6 By End User
  • 10.5.7 Brazil
  • 10.5.8 Argentina
  • 10.5.9 Peru
  • 10.5.10 Chile
  • 10.5.11 South East Asia
  • 10.5.12 Rest of Latin America
• 10.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 10.6.1 By Product & Service
  • 10.6.2 By Sample Type
  • 10.6.3 By Storage Type
  • 10.6.4 By Ownership
  • 10.6.5 By Application
  • 10.6.6 By End User
  • 10.6.7 Saudi Arabia
  • 10.6.8 UAE
  • 10.6.9 Israel
  • 10.6.10 South Africa
  • 10.6.11 Rest of the Middle East And Africa

Chapter 11. COMPETITIVE LANDSCAPE

• 11.1. Recent Developments
• 11.2. Company Categorization
• 11.3. Supply Chain & Channel Partners (based on availability)
• 11.4. Market Share & Positioning Analysis (based on availability)
• 11.5. Vendor Landscape (based on availability)
• 11.6. Strategy Mapping

Chapter 12. COMPANY PROFILES OF GLOBAL BIOBANKING INDUSTRY

• 12.1. Top Companies Market Share Analysis
• 12.2. Company Profiles
  • 12.2.1 Merck KGaA
  • 12.2.2 Thermo Fisher ScientificInc
  • 12.2.3 Becton, Dickinson And Company
  • 12.2.4 PHC Holdings Corporation
  • 12.2.5 AvantorInc
  • 12.2.6 Greiner Holding AG
  • 12.2.7 AzentaInc
  • 12.2.8 Tecan Trading AG
  • 12.2.9 Hamilton Company
  • 12.2.10 CryoportInc
  • 12.2.11 Micronic
  • 12.2.12 AMSBIO
  • 12.2.13 Bay Biosciences LLC
  • 12.2.14 BioKryo
  • 12.2.15 SPT Labtech